Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 93346

6 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
October 31, 2023
Product types
Drug
Classifications
Class I
Statuses
Ongoing
Recalling firm wording
Cardinal Health Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

6 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 6

LEADER brand Eye Irritation Relief (Polyvinyl alcohol 0.5%, Povidone 0.6%, Tetrahydrozoline Hydrochloride 0.05%), 0.5 FL OZ (15 mL) dropper bottles, Sterile, Distributed By Cardinal Health, Dublin, Ohio 43017, Made in India NDC: 70000-0087-1

D-0131-2024
Recall number
D-0131-2024
Initiated
October 31, 2023
Classification
Class I
Status
Ongoing
Recalling firm
Cardinal Health Inc.
Quantity
11629 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

Code information

ALL LOTS

Distribution pattern

Nationwide in the USA

drug · product 2 of 6

LEADER brand Dry Eye Relief (Carboxymethylcellulose Sodium, 1%); 0.5 FL OZ (15 mL) dropper bottle, Sterile, Distributed By Cardinal Health, Dublin, Ohio. 43017, Made in India NDC: 70000-0089-1

D-0132-2024
Recall number
D-0132-2024
Initiated
October 31, 2023
Classification
Class I
Status
Ongoing
Recalling firm
Cardinal Health Inc.
Quantity
21,802 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

Code information

ALL LOTS

Distribution pattern

Nationwide in the USA

drug · product 3 of 6

LEADER brand Lubricant Eye Drops (Carboxymethylcellulose Sodium, 0.5%); 0.5 FL OZ (15 mL) dropper bottles, Sterile, Distributed By Cardinal Health, Dublin, Ohio 43017. Made in India NDC: 70000-0090-1

D-0133-2024
Recall number
D-0133-2024
Initiated
October 31, 2023
Classification
Class I
Status
Ongoing
Recalling firm
Cardinal Health Inc.
Quantity
119,871 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

Code information

ALL LOTS

Distribution pattern

Nationwide in the USA

drug · product 4 of 6

LEADER brand Lubricant Eye Drops (Carboxymethylcellulose Sodium, 0.5%); 2 bottles, 0.5 FL OZ (15 mL) dropper bottles, Sterile, Distributed By Cardinal Health, Dublin, Ohio 43017, Made in India NDC:70000-0090-2 (Carton); 70000-0090-1 (Bottle)

D-0134-2024
Recall number
D-0134-2024
Initiated
October 31, 2023
Classification
Class I
Status
Ongoing
Recalling firm
Cardinal Health Inc.
Quantity
28477 cartons

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

Code information

ALL LOTS

Distribution pattern

Nationwide in the USA

drug · product 5 of 6

LEADER brand Dry Eye Relief (Polyethylene Glycol 400, 0.4% Propylene Glycol, 0.3%); 0.33 FL OZ (10 mL) dropper bottle, Sterile, Distributed By Cardinal Health, Dublin, Ohio 43017, Made in India NDC: 70000-0088-1

D-0135-2024
Recall number
D-0135-2024
Initiated
October 31, 2023
Classification
Class I
Status
Ongoing
Recalling firm
Cardinal Health Inc.
Quantity
11,782 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

Code information

ALL LOTS

Distribution pattern

Nationwide in the USA

drug · product 6 of 6

LEADER brand Lubricant Eye Drops (Propylene Glycol, 0.6%); 0.33 FL OZ (10 mL) dropper bottles, Sterile, Distributed By Cardinal Health, Dublin, Ohio 43017. Made in India NDC: 70000-0587-1

D-0136-2024
Recall number
D-0136-2024
Initiated
October 31, 2023
Classification
Class I
Status
Ongoing
Recalling firm
Cardinal Health Inc.
Quantity
8,784 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.

Code information

ALL LOTS

Distribution pattern

Nationwide in the USA